Novo Nordisk's pricing methods from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price tag gouging, pointing out the stark contrast between U.S. charges and those in Europe and copyright.Novo Nordisk A/S is really a Danish multinational pharmaceutical company headquartered in Bagsværd,[3]